BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31473907)

  • 21. The Symptom Checklist-90: Obsessive-Compulsive Subscale: A reliability and validity study.
    Kim SW; Dysken MW; Kuskowski M
    Psychiatry Res; 1992 Jan; 41(1):37-44. PubMed ID: 1561287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Yale-Brown Obsessive-Compulsive Scale: a reliability and validity study.
    Kim SW; Dysken MW; Kuskowski M
    Psychiatry Res; 1990 Oct; 34(1):99-106. PubMed ID: 2267266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions.
    Rosario-Campos MC; Miguel EC; Quatrano S; Chacon P; Ferrao Y; Findley D; Katsovich L; Scahill L; King RA; Woody SR; Tolin D; Hollander E; Kano Y; Leckman JF
    Mol Psychiatry; 2006 May; 11(5):495-504. PubMed ID: 16432526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lisdexamfetamine for binge eating disorder in adults: a systematic review of the efficacy and safety profile for this newly approved indication - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2015 Apr; 69(4):410-21. PubMed ID: 25752762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defining clinical severity in adults with obsessive-compulsive disorder.
    Storch EA; De Nadai AS; Conceição do Rosário M; Shavitt RG; Torres AR; Ferrão YA; Miguel EC; Lewin AB; Fontenelle LF
    Compr Psychiatry; 2015 Nov; 63():30-5. PubMed ID: 26555489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy, safety, and tolerability of nivasorexant in adults with binge-eating disorder: A randomized, Phase II proof of concept trial.
    McElroy SL; Coloma PM; Berger B; Guerdjikova AI; Joyce JM; Liebowitz MR; Pain S; Rabasa C
    Int J Eat Disord; 2023 Nov; 56(11):2120-2130. PubMed ID: 37584285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychometric properties of the Children's Yale-Brown Obsessive Compulsive Scale in youth with autism spectrum disorders and obsessive-compulsive symptoms.
    Wu MS; McGuire JF; Arnold EB; Lewin AB; Murphy TK; Storch EA
    Child Psychiatry Hum Dev; 2014; 45(2):201-11. PubMed ID: 23827959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Yale-Brown Obsessive Compulsive Scale: A Reliability Generalization Meta-Analysis.
    López-Pina JA; Sánchez-Meca J; López-López JA; Marín-Martínez F; Núñez-Núñez RM; Rosa-Alcázar AI; Gómez-Conesa A; Ferrer-Requena J
    Assessment; 2015 Oct; 22(5):619-28. PubMed ID: 25268017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing Obsessive-Compulsive Symptom Measurement With the Yale-Brown Obsessive-Compulsive Scales-Second Edition.
    Vogt GS; Avendaño-Ortega M; Schneider SC; Goodman WK; Storch EA
    J Psychiatr Pract; 2022 Jul; 28(4):294-309. PubMed ID: 35797686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychometric evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale.
    Storch EA; Murphy TK; Geffken GR; Soto O; Sajid M; Allen P; Roberti JW; Killiany EM; Goodman WK
    Psychiatry Res; 2004 Nov; 129(1):91-8. PubMed ID: 15572188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and Psychometric Evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale Second Edition.
    Storch EA; McGuire JF; Wu MS; Hamblin R; McIngvale E; Cepeda SL; Schneider SC; Rufino KA; Rasmussen SA; Price LH; Goodman WK
    J Am Acad Child Adolesc Psychiatry; 2019 Jan; 58(1):92-98. PubMed ID: 30577944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of an interview-only version of the Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS) in treatment-seeking youth with obsessive-compulsive disorder.
    Cervin M; Perrin S; Olsson E; Claesdotter-Knutsson E; Lindvall M
    Psychiatry Res; 2019 Jan; 271():171-177. PubMed ID: 30481695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The clinical assessment of obsessive-compulsive symptoms in children and adolescents - A study with the Children's Yale-Brown Obsessive-Compulsive Scale (CY-BOCS-D)].
    Goletz H; Döpfner M
    Z Kinder Jugendpsychiatr Psychother; 2020; 48(3):178-193. PubMed ID: 30556768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Congruence and discrepancy between self-rated and clinician-rated symptom severity on the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) before and after a low-intensity intervention.
    Hauschildt M; Dar R; Schröder J; Moritz S
    Psychiatry Res; 2019 Mar; 273():595-602. PubMed ID: 30716599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the COVID-19 Pandemic on Obsessive-Compulsive Symptoms Among University Students: Prospective Cohort Survey Study.
    Ji G; Wei W; Yue KC; Li H; Shi LJ; Ma JD; He CY; Zhou SS; Zhao Z; Lou T; Cheng J; Yang SC; Hu XZ
    J Med Internet Res; 2020 Sep; 22(9):e21915. PubMed ID: 32931444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reliability and validity of the Yale-Brown Obsessive-Compulsive Scale in schizophrenia patients.
    de Haan L; Hoogeboom B; Beuk N; Wouters L; Dingemans PM; Linszen DH
    Psychopharmacol Bull; 2006; 39(1):25-30. PubMed ID: 17065972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Convergent and discriminant validity of the Yale-Brown Obsessive-Compulsive Scale Symptom Checklist.
    Mataix-Cols D; Fullana MA; Alonso P; Menchón JM; Vallejo J
    Psychother Psychosom; 2004; 73(3):190-6. PubMed ID: 15031592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lisdexamfetamine Dimesylate for Adults with Moderate to Severe Binge Eating Disorder: Results of Two Pivotal Phase 3 Randomized Controlled Trials.
    McElroy SL; Hudson J; Ferreira-Cornwell MC; Radewonuk J; Whitaker T; Gasior M
    Neuropsychopharmacology; 2016 Apr; 41(5):1251-60. PubMed ID: 26346638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The children's Yale-Brown obsessive-compulsive scale: psychometric properties of child- and parent-report formats.
    Storch EA; Murphy TK; Adkins JW; Lewin AB; Geffken GR; Johns NB; Jann KE; Goodman WK
    J Anxiety Disord; 2006; 20(8):1055-70. PubMed ID: 16503111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can the Yale-Brown Obsessive Compulsive Scale be used to assess trichotillomania? A preliminary report.
    Stanley MA; Prather RC; Wagner AL; Davis ML; Swann AC
    Behav Res Ther; 1993 Feb; 31(2):171-7. PubMed ID: 8442741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.